WP
INBS icon

WealthShield Partners’s Intelligent Bio Solutions INBS Stock Holding History

WealthShield Partners’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20
Closed -$71K – 354
2021
Q4 		$71K Hold
20
– – 0.01% 279
2021
Q3 		$124K Hold
20
– – 0.03% 230
2021
Q2 		$194K Buy
+20
New +$191K 0.03% 263

Other funds holding INBS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

WealthShield Partners's INBS Position: Q1 2022 in Review

WealthShield Partners sold out of Intelligent Bio Solutions (INBS) in Q1 2022, closing a stake of 20 shares — an estimated $71K sold.

WealthShield Partners first reported a position in INBS in Q2 2021 and held it in 3 quarters. The position peaked at $194K in Q2 2021. 13 funds tracked by Wall St. Rank hold INBS as of Q1 2022.

  • WealthShield Partners reported no remaining Intelligent Bio Solutions position as of Q1 2022 after selling out during the quarter.
  • WealthShield Partners sold 20 Intelligent Bio Solutions shares in Q1 2022, an estimated $71K.
  • WealthShield Partners first reported a position in Intelligent Bio Solutions in Q2 2021 and held it in 3 quarters.
  • WealthShield Partners's Intelligent Bio Solutions position peaked at $194K in Q2 2021.
  • 13 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q1 2022.

Based on WealthShield Partners's 13F filing for Q1 2022, filed 9 May 2022.